{"id":987636531,"date":"2018-01-16T03:47:24","date_gmt":"2018-01-16T02:47:24","guid":{"rendered":"https:\/\/p4h.world\/news\/tout-juste-sorti-de-presse-rapport-sur-la-conception-des-prestations-et-la-politique-pharmaceutique-le-cas-de-lindonesie-par-la-giz\/"},"modified":"2018-01-16T03:47:24","modified_gmt":"2018-01-16T02:47:24","slug":"tout-juste-sorti-de-presse-rapport-sur-la-conception-des-prestations-et-la-politique-pharmaceutique-le-cas-de-lindonesie-par-la-giz","status":"publish","type":"news","link":"https:\/\/p4h.world\/fr\/news\/tout-juste-sorti-de-presse-rapport-sur-la-conception-des-prestations-et-la-politique-pharmaceutique-le-cas-de-lindonesie-par-la-giz\/","title":{"rendered":"Tout juste sorti de presse &#8211; Rapport sur la conception des prestations et la politique pharmaceutique. Le cas de l&#8217;Indon\u00e9sie par la GIZ"},"content":{"rendered":"<p><span><span><span><span><span>&nbsp;<a href=\"https:\/\/socialprotection.us11.list-manage.com\/track\/click?u=b498450933cbd79af8fc3e40b&amp;id=cf204b0844&amp;e=68fd018652\" target=\"_blank\" rel=\"noopener\"><br \/>\n  <span>&#8220;<em><span>Viabilit\u00e9 financi\u00e8re et efficacit\u00e9 de la couverture du syst\u00e8me indon\u00e9sien d&#8217;assurance maladie &#8211; Le r\u00f4le des <\/span><\/em><\/span><br \/>\n<\/a><em><br \/>\n  <span><br \/>\n    <a href=\"https:\/\/socialprotection.us11.list-manage.com\/track\/click?u=b498450933cbd79af8fc3e40b&amp;id=4fa69e3556&amp;e=68fd018652\"><br \/>\n      <span>des prestations<\/span><br \/>\n    <\/a><br \/>\n  <\/span><br \/>\n<\/em><a href=\"https:\/\/socialprotection.us11.list-manage.com\/track\/click?u=b498450933cbd79af8fc3e40b&amp;id=272ef2a764&amp;e=68fd018652\"><br \/>\n  <em><br \/>\n    <span><br \/>\n      <span> des prestations et de la politique pharmaceutique<\/span><br \/>\n    <\/span><br \/>\n  <\/em><br \/>\n  <span>&#8220;<\/span><br \/>\n<\/a>. L&#8217;\u00e9valuation fait partie de la contribution allemande \u00e0 l&#8217;initiative des syst\u00e8mes de protection sociale de l&#8217;Union europ\u00e9enne (EU-SPS).<\/span><\/span><\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &#8220;Viabilit\u00e9 financi\u00e8re et efficacit\u00e9 de la couverture du syst\u00e8me indon\u00e9sien d&#8217;assurance maladie &#8211; Le r\u00f4le des des prestations des prestations et de la politique pharmaceutique &#8220; . L&#8217;\u00e9valuation fait partie de la contribution allemande \u00e0 l&#8217;initiative des syst\u00e8mes de protection sociale de l&#8217;Union europ\u00e9enne (EU-SPS).<\/p>\n","protected":false},"author":546,"featured_media":987533346,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[],"tags":[2454,2371],"acf":[],"_links":{"self":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/news\/987636531"}],"collection":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/users\/546"}],"replies":[{"embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/comments?post=987636531"}],"version-history":[{"count":0,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/news\/987636531\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/media\/987533346"}],"wp:attachment":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/media?parent=987636531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/categories?post=987636531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/tags?post=987636531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}